Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer: A Controlled, Randomized, Double Blinded Trial
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Free of atrial fibrillation
31082009
Yes
Lars R Zebis, MD, Ph.D.
Principal Investigator
Aarhus University Hospital Skejby
Denmark: Danish Medicines Agency
2612-3681
NCT00724581
August 2008
December 2009
Name | Location |
---|